ArticleFrontiers in oncology2022

PRLHR Immune Genes Associated With Tumor Mutation Burden can be Used as Prognostic Markers in Patients With Gliomas.

Yi Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.